Study to Evaluate the Safety, Reactogenicity, and Immunogenicity of mRNA-1403 and mRNA-1405 to Prevent Norovirus Acute Gastroenteritis in Healthy Adults 18 to 49 Years of Age and 60 to 80 Years of Age.

Condition:   Norovirus Acute Gastroenteritis Interventions:   Biological: mRNA-1403;   Biological: mRNA-1405;   Biological: Placebo Sponsor:   ModernaTX, Inc. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials